Skip to main content
. 2021 Aug 3;22(4):703. doi: 10.3892/ol.2021.12964

Figure 1.

Figure 1.

YAP and TAZ are prognostic factors in gastric cancer. Images from the Humap Protein Atlas showed that expression levels of (A) YAP and (B) TAZ in gastric cancer (tumor; n=408), as indicated by immunohistochemistry, were significantly higher than in the normal tissue (normal; n=211). Higher expressions of (C) YAP and (D) TAZ in gastric cancers are associated with significantly poorer prognoses relative to cancers with lower expression levels. **P<0.01 vs. control. YAP, yes-associated protein; TAZ, transcriptional co-activator with a PDZ-binding domain.